International audience
-
April 2020 (v1)Journal articleUploaded on: December 4, 2022
-
January 1, 2013 (v1)Journal article
The anion exchanger 1 (AE1), a member of bicarbonate transporter family SLC4, mediates an electroneutral chloride/bicarbonate exchange in physiological conditions. However, some point mutations in AE1 membrane-spanning domain convert the electroneutral anion exchanger into a Na(+) and K(+) conductance or induce a cation leak in a still...
Uploaded on: February 28, 2023 -
May 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
April 2016 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
July 2016 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
2022 (v1)Publication
The optimal conditioning regimen prior haploidentical stem cell transplantation (Haplo-SCT) with post transplantation cyclophosphamide (PT-Cy) for acute myeloid leukemia (AML) remains unknown. A non-myeloablative conditioning (NMAC) regimen (cyclophosphamide + fludarabine + TBI 2 Gy [CyFluTBI]) is a safe approach, but relapse incidence remains...
Uploaded on: February 28, 2024 -
December 31, 2014 (v1)Journal article
International audience
Uploaded on: February 28, 2023 -
January 2016 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
June 2020 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
December 2012 (v1)Journal articleSerum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.
Regarding the frequency of muscular complains with the use of tyrosine kinase inhibitors (TKIs), we hypothesize that creatine kinase (CK) elevation may be more frequent than usually reported. We conducted a prospective study on patients treated with TKIs for solid tumors, to assess the incidence of CK increase on treatment. Most of the patients...
Uploaded on: October 11, 2023 -
December 2012 (v1)Journal articleSerum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.
Regarding the frequency of muscular complains with the use of tyrosine kinase inhibitors (TKIs), we hypothesize that creatine kinase (CK) elevation may be more frequent than usually reported. We conducted a prospective study on patients treated with TKIs for solid tumors, to assess the incidence of CK increase on treatment. Most of the patients...
Uploaded on: December 4, 2022 -
January 2017 (v1)Journal article
International audience
Uploaded on: February 28, 2023 -
January 2018 (v1)Journal articleLes points chauds de l'actualité en 2017. Une sélection du comité de rédaction du Bulletin du Cancer
International audience
Uploaded on: February 28, 2023 -
September 1, 2015 (v1)Journal article
Purpose The aim of this randomized, phase II trial was to explore the activity and safety of adding bevacizumab to paclitaxel once per week in treatment of angiosarcomas (AS). Methods Patients were treated with paclitaxel alone (90 mg/m 2 per week for six cycles of 28 days each; arm A) or with paclitaxel combined with bevacizumab (10 mg/kg once...
Uploaded on: December 3, 2022 -
March 2015 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
October 14, 2013 (v1)Journal article
INTRODUCTION: Primary cardiac sarcomas (PCS) are rare tumours of dismal prognosis. METHODS: Data of 124 patients with PCS referred to institutions of the French Sarcoma Group (FSG) from 1977 and 2010 were reviewed. RESULTS: Median age was 48.8years. PCS were poorly-differentiated sarcomas (N=45, 36.3%), angiosarcomas (N=40, 32.3%),...
Uploaded on: December 3, 2022 -
December 2014 (v1)Journal article
Background: Few targeted therapies (TTs) are registered for sarcoma treatment despite numerous phase II studies and yet there are potential treatment options for patients after standard treatment escape. The French Sarcoma Group - Bone Tumor Study Group (GSF-GETO) created a national registry to evaluate the outcome of patients treated with...
Uploaded on: December 3, 2022 -
October 14, 2013 (v1)Journal article
INTRODUCTION: Primary cardiac sarcomas (PCS) are rare tumours of dismal prognosis. METHODS: Data of 124 patients with PCS referred to institutions of the French Sarcoma Group (FSG) from 1977 and 2010 were reviewed. RESULTS: Median age was 48.8years. PCS were poorly-differentiated sarcomas (N=45, 36.3%), angiosarcomas (N=40, 32.3%),...
Uploaded on: October 11, 2023 -
July 1, 2024 (v1)Journal article
In this SFGM-TC registry study, we report the results after stem cell transplantation (HSCT) in 305 myelofibrosis patients, in order to determine potential risk factors associated with outcomes, especially regarding previous treatment with ruxolitinib. A total of 102 patients were transplanted from an HLA-matched-sibling donor (MSD), and 143...
Uploaded on: September 6, 2024